Design and development of polymers for gene delivery

Nature Reviews Drug Discovery

Volumn 4, Issue 7, 2005, Pages 581-593

  Pack, Daniel W ^a   Hoffman, Allan S ^b   Pun, Suzie ^b   Stayton, Patrick S ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIETHYLAMINOETHANOL; ALPHA CYCLODEXTRIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA CYCLODEXTRIN; CALCIUM PHOSPHATE; CARBOXYLIC ACID DERIVATIVE; CARBOXYLIC ACID POLYMER; CYCLODEXTRIN; DENDRIMER; DEXTRAN; DNA; DNA ENZYME; ENZYME; GAMMA CYCLODEXTRIN; IMIDAZOLE DERIVATIVE; LIPID; LIPOPLEX; MACROGOL; N (2 HYDROXYPROPYL)METHACRYLAMIDE; OLIGOSACCHARIDE; PLASMID DNA; POLY(BETA AMINO ESTER); POLY[ALPHA (4 AMINOBUTYL) LEVO GLYCOLIC ACID]; POLYACRYLIC ACID; POLYAMINOACID; POLYAMIODAMINE; POLYBUTYLACRYLIC ACID; POLYETHYLACRYLIC ACID; POLYETHYLENEIMINE; POLYGLYCOLIC ACID; POLYHISTIDINE; POLYLYSINE; POLYMER; POLYMETHACRYLIC ACID; POLYPROPYLACRYLIC ACID; PROTEIN; RNA; SMALL INTERFERING RNA; SUGAR; UNCLASSIFIED DRUG; VIRUS VECTOR;

BIODEGRADABILITY; CELL SPECIFICITY; COMPLEX FORMATION; DNA PACKAGING; DRUG STABILITY; GENE TARGETING; GENE THERAPY; HUMAN; INTRACELLULAR TRANSPORT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; REVIEW; SAFETY; STRUCTURE ACTIVITY RELATION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; CYCLODEXTRINS; DRUG DESIGN; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMIDAZOLES; POLYMERS;

EID: 22144447455     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1775     Document Type: Review

References (182)

1. Mulligan, R. C. The basic science of gene therapy. Science 260, 926-932 (1993).
2. Walsh, C. E. Gene therapy progress and prospects: gene therapy for the hemophilias. Gene Ther. 10, 999-1003 (2003).
3. van Deutekom, J. C. T. & van Ommen, G. J. B. Advances in Duchenne muscular dystrophy gene therapy. Nature Rev. Genet. 4, 774-783 (2003).
4. Ferrari, S., Geddes, D. M. & Alton, E. W. F. W. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv. Drug Deliv. Rev. 54, 1373-1393 (2002).
5. Dzau, V. J., Deatt, K., Pompilio, G. & Smith, K. Current perceptions of cardiovascular gene therapy. Am. J. Cardiol. 92, 18-23 (2003).
6. Burton, E. A., Glorioso, J. C. & Fink, D. J. Gene therapy progress and prospects: Parkinson's disease. Gene Ther. 10, 1721-1727 (2003).
7. Alisky, J. M. & Davidson, B. L. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases. Hum. Gene Ther. 11, 2315-2329 (2000).
8. Tuszynski, M. H. Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol. 1, 51-57 (2002).
9. Bunnell, B. A. & Morgan, R. A. Gene therapy for infectious diseases. Clin. Microbiol. Rev. 11, 42-52 (1998).
10. Cutroneo, K. R. Gene therapy for tissue regeneration. J. Cell. Biochem. 88, 418-425 (2003).
11. Vile, R. G., Russell, S. J. & Lemoine, N. R. Cancer gene therapy: hard lessons and new courses. Gene Ther. 7, 2-8 (2000).
12. Kerr, D. Clinical development of gene therapy for colorectal cancer. Nature Rev. Cancer 3, 615-622 (2003).
13. McNeish, L. A., Bell, S. J. & Lemoine, N. R. Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes. Gene Ther. 11, 497-503 (2004).
14. Nabel, E. G. Gene therapy for cardiovascular diseases. J. Nucl. Cardiol. 6, 69-75 (1999).
15. Liu, M. A. DNA vaccines: a review. J. Intern. Med. 253, 402-410 (2003).
16. Blaese, R. M. et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270, 475-480 (1995).
17. Cavazzana-Calvo, M. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672 (2000).
18. Kay, M. A. et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nature Genet. 24, 257-261 (2000).
19. Khuri, F. R. et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Med. 6, 879-885 (2000).
20. Gene Therapy Clinical Trials [online] (2005).
21. Verma, I. M. & Somia, N. Gene therapy - promises, problems and prospects. Nature 389, 239-242 (1997).
22. During, M. J. Adeno-associated virus as a gene delivery system. Adv. Drug Deliv. Rev. 27, 83-94 (1997).
23. Vile, R. G., Tuszynski, A. & Castleden, S. Retroviral vectors: from laboratory tools to molecular medicines. Mol. Biotechnol. 5, 139-158 (1996).
24. Felgner, P. L. et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84, 7413 (1987).
25. Koltover, I., Salditt, T., Radler, J. O. & Safinya, C. R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281, 78-81 (1998).
26. Zabner, J. Cationic lipids used in gene transfer. Adv. Drug Deliv. Rev. 27, 17-28 (1997).
27. Fillion, M. C. & Phillips, N. C. Major limitations in the use of cationic liposomes for DNA delivery. Int. J. Pharm. 162, 159-170 (1998).
28. Abdelhady H. G. et al. Direct real-time molecular scale visualisation of the degradation of condensed DNA complexes exposed to DNase I. Nucleic Acids Res. 31, 4001-4005 (2003).
29. Bloomfield, V. A. DNA condensation by multivalent cations. Biopolymers 44, 269-282 (1997).
30. Wagner, E., Cotten, M., Foisner, R. & Birnstiel, M. L. Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl Acad. Sci. USA 88, 4255-4259 (1991).
31. Hansma, H. G. et al. DNA condensation for gene therapy as monitored by atomic force microscopy. Nucleic Acids Res. 26, 2481-2487 (1998).
32. Lai, E. & van Zanten, J. H. Monitoring DNA/poly-L-lysine polyplex formation with time-resolved multiangle laser light scattering. Biophys. J. 80, 864-873 (2001).
33. Kabanov, A. V. et al. DNA interpolyelectrolyte complexes as a tool for efficient cell transformation. Biopolymers 31, 1437-1443 (1991).
34. Wadhwa, M. S., Collard, W. T., Adami, R. C., McKenzie, D. L. & Rice, K. G. Peptide-mediated gene delivery: influence of peptide structure on gene expression. Bioconjug. Chem. 8, 81-88 (1997).
35. Plank, C., Tang, M. X., Wolfe, A. R. & Szoka, F. C. Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum. Gene Ther. 10, 319-332 (1999).
36. Schaffer, D. V., Fidelman, N. A., Dan, N. & Lauffenburger, D. A. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 67, 598-606 (2000).
37. Wolfert, M. A. et al. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug. Chem. 10, 993-1004 (1999).
38. Zelphati, O. & Szoka, F. C. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl Acad. Sci. USA 93, 11493-11498 (1996).
39. Dash, P. R., Read, M. L., Barrett, L. B., Wolfert, M. A. & Seymour, L. W. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther. 6, 643-650 (1999).
40. Ogris, M., Brunner, S., Schuller, S., Kircheis, R. & Wagner, E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6, 595-605 (1999).
41. Toncheva, V. et al. Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim. Biophys. Acta 1380, 354-368 (1998).
42. Oupicky, D. et al. Steric stabilization of poly-L-lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]. Bioconjug. Chem. 11, 492-501 (2000).
43. Dash, P. R. et al. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J. Biol. Chem. 275, 3793-3802 (2000).
44. Howard, K. A. et al. Influence of cationic polymers on the biophysical properties of polyelectrolyte complexes formed by self-assembly with DNA. Biochim. Biophys. Acta 1475, 245-255 (2000).
45. Wang, W., Tetley, L. & Uchegbu, I. F. The level of hydrophobic substitution and the molecular weight of amphiphilic poly-L-lysine-based polymers strongly effects their assembly into polymeric bilayer vesicles. J. Colloid. Int. Sci. 237, 200-207 (2001).
46. Erbacher, P. et al. Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum. Gene Ther. 7, 721-729 (1996).
47. Nishikawa, M., Takemura, S., Takakura, Y. & Hashida, M. Targeted delivery of plasmid DNA to hepatocytes in vivo optimization of the pharmacokinetics of plasmid DNA galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J. Pharm. Exp. Ther. 287, 408-415 (1998).
48. Kircheis, R. et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8, 28-40 (2001).
49. Mishra, S., Webster, P. & Davis, M. E. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. Cell Biol. 83, 97-111 (2004).
50. Erbacher, P., Roche, A. C., Monsigny, M. & Midoux, P. Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconjug. Chem. 6, 401-410 (1995).
51. Ferkol, T., Perales, J. C., Mularo, F. & Hanson, R. W. Receptor-mediated gene transfer into macrophages. Proc. Natl Acad. Sci. USA 93, 101-105 (1996).
52. Zanta, M.-A., Boussif, O., Adib, A. & Behr, J.-P. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. [i Bioconjug. Chem. 8, 839-844 (1997).
53. Bettinger, T., Remy, J. S. & Erbacher, P. Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. Bioconjug. Chem. 10, 558-561 (1999).
54. Leamon, C. P., Weigl, D. & Hendren, R. W. Folate copolymer-mediated transfection of cultured cells. Bioconjug. Chem. 10, 947-957 (1999).
55. Wu, G. Y. & Wu, C. H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429-4432 (1987).
56. Wu, G. Y. & Wu, C. H. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263, 14621-14624 (1988).
57. Wu, C. H., Wilson, J. M. & Wu, G. Y. Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J. Biol. Chem. 264, 16985-16987 (1989).
58. Wu, G. Y. et al. Receptor-mediated gene delivery in vivo. J. Biol. Chem. 266, 14338-14342 (1991).
59. Cotten, M. et al. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc. Natl Acad. Sci. USA 87, 4033-4037 (1990).
60. Wagner, E., Zenke, M., Cotten, M., Beug, H. & Birnstiel, M. L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl Acad. Sci. USA 87, 3410-3414 (1990).
61. Zenke, M. et al. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc. Natl Acad. Sci. USA 87, 3655-3659 (1990).
62. Zatloukal, K. et al. Transferrinfection: a highly efficient way to express gene constructs in eukaryotic cells. Ann. NY Acad. Sci. 660, 136-153 (1992).
63. Schaffer, D. V., Neve, R. L. & Lauffenburger, D. A. Use of the green fluorescent protein as a quantitative reporter of epidermal growth factor receptor-mediated gene delivery. Tissue Eng. 3, 53-63 (1997).
64. Schaffer, D. V. in Chemical Engineering 125 (Massachusetts Institute of Technology, Cambridge, Massachusetts, 1998).
65. Kircheis, R. et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4, 409-418 (1997).
66. Harbottle, R. P. et al. An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Hum. Gene Ther. 9, 1037-1047 (1998).
67. Schaffer, D. V. & Lauffenburger, D. A. Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. J. Biol. Chem. 273, 28004-28009 (1998).
68. Tsang, W. C., Haselton, F. R. & Giorgio, T. D. Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J. Biol. Chem. 272, 25641-25647 (1997).
69. Mukherjee, S., Ghosh, R. N. & Maxfield, F. R. Endocytosis. Physiol. Rev. 77, 759-803 (1997).
70. Mislick, K. A. & Baldeschwieler, J. D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl Acad. Sci. USA 93, 12349-12354 (1996).
71. Erbacher, P., Roche, A. C., Monsigny M. & Midoux, P. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp. Cell Res. 225, 186-194 (1996).
72. Curiel, D. T., Agarwal, S., Wagner, E. & Cotten, M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl Acad. Sci. USA 88, 8850-8854 (1991).
73. Cristiano, R. J., Smith, L. c. & Woo, S. L. C. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl Acad. Sci. USA 90, 2122-2126 (1993).
74. Wagner, E. et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl Acad. Sci. USA 89, 6099-6103 (1992).
75. Cotten, M. et al. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl Acad. Sci. USA 89, 6094-6098 (1992).
76. Wagner, E., Plank, C., Zatloukal, K., Cotten, M. & Birnstiel, M. L. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl Acad. Sci. USA 89, 7934-7938 (1992).
77. Plank, C., Zatloukal, K., Cotten, M., Mechtler, K. & Wagner, E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug. Chem. 3, 533-539 (1992).
78. Plank, C., Oberhauser, B., Mechtler, K., Koch, C. & Wagner, E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269, 12918-12924 (1994).
79. Midoux, P. et al. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res. 21, 871-878 (1993).
80. Wyman, T. B. et al. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36, 3008-3017 (1997).
81. Lee, H., Jeong, J. H. & Park, T. G. A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. J. Control. Release 76, 183-192 (2001).
82. Vaysse, L., Burgelin, I., Merlio, J. P. & Arveiler, B. Improved transfection using epithelial cell line-selected ligands and fusogenic peptides. Biochim. Biophys. Acta 1475, 369-376 (2000).
83. Luby-Phelps, K., Castle, P. E., Taylor, D. L. & Lanni, F. Hindered diffusion of inert tracer particles in the cytoplasm of mouse 3T3 cells. Proc. Natl Acad. Sci. USA 84, 4910-4913 (1987).
84. Lukacs, G. L. et al. Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 275, 1625-1629 (2000).
85. Lechardaeur, D. et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6, 482-497 (1999).
86. Suh, J., Wirtz, D. & Hanes, J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl Acad. Sci. USA 100, 3878-3882 (2003).
87. Subramanian, A., Ranganathan, P. & Diamond, S. L. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat. Biotechnol. 17, 873-877 (1999).
88. Brunner, S. et al. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 7, 401-407 (2000).
89. Chan, C. K. & Jans, D. A. Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. Hum. Gene Ther. 10, 1695-1702 (1999).
90. Chan, C. K., Senden, T.. & Jans, D. A. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines. Gene Ther. 7, 1690-1697 (2000).
91. Sebestyén, M. G. et al. DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA. Nature Biotechnol. 16, 80-85 (1998).
92. Brandén, L. J., Mohamed, A. J. & Smith, C. I. E. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nature Biotechnol. 17, 784-787 (1999).
93. Ciolina, C. et al. Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin α. Bioconjug. Chem. 10, 46-55 (1999).
94. Bremner, K. H., Seymour, L. W., Logan, A. & Read, M. L. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjug. Chem. 15, 152-161 (2004).
95. Wilson, G., Dean, B. S., Wang, G. & Dean, D. A. DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA. J. Biol. Chem. 16, 80-85 (1998).
96. Erbacher, P., Roche, A. C., Monsigny, M. & Midoux, P. The reduction of the positive charges of polylysine by partial gluconoylation increases the transfection efficiency of polylysine/DNA complexes. Biochim. Biophys. Acta 1324, 27-36 (1997).
97. Banaszczyk, M. G. et al. Poly-L-lysine-graft-PEG-comb-type polycation copolymers for gene delivery. J. Macromol. Sci. A 36, 1061-1084 (1999).
98. Zauner, W., Ogris, M. & Wagner, E. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv. Drug Deliv. Rev. 30, 97-113 (1998).
99. Cotten, M., Wagner, E. & Birnstiel, M. L. Receptor-mediated transport of DNA into eukaryotic cells. Meth. Enz. 217, 618-644 (1993).
100. Perales, J. C., Ferkol, T., Geegen, H., Ratnoff, O. D. & Hanson, R. W. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc. Natl Acad. Sci. USA 91, 4086-4090 (1994).
101. Wadhwa, M. S., Knoell, D. L., Young, A. P. & Rice, K. G. Targeted gene delivery with a low molecular weight glycopeptide carrier. Bioconjug. Chem. 6, 283-291 (1995).
102. Hashida, M., Takemura, S., Nishikawa, M. & Takakura, Y. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). Adv. Drug Deliv. Rev. 53, 301-310 (1998).
103. Suh, W., Chung, J.-K., Park, S.-H. & Kim, S. W. Anti-JL1 antibody-conjugated poly(L-lysine) for targeted gene delivery to leukemia T cells. J. Control. Release 72, 171-178 (2001).
104. Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA 92, 7297-7301 (1995).
105. Diebold, S. S., Kursa, M., Wagner, E., Cotten, M. & Zenke, M. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J. Biol. Chem. 274, 19087-19094 (1999).
106. Kircheis, R., Blessing, R., Brunner, S., Wightman, L. & Wagner, E. Tumor targeting with surface-shielded ligand-polycation DNA complexes. J. Control. Release 72, 165-170 (2001).
107. Wojda, U. & Miller, J. L. Targeted transfer of polyethylenimine-avidin-DNA bioconjugates to hematopoietic cells using biotinylated monoclonal antibodies. J. Pharm. Sci. 89, 674-681 (2000).
108. Abdallah, B. et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum. Gene Ther. 7, 1947-1954 (1996).
109. Goula, D. et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther. 5, 712-717 (1998).
110. Boletta, A. et al. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther. 8, 1243-1251 (1997).
111. Goula, D. et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 5, 1291-1295 (1998).
112. Ferrari, S. et al. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Biochim. Biophys. Acta 1447, 219-225 (1999).
113. Coll, J. L. et al. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum. Gene Ther. 10, 1659-1666 (1999).
114. Behr, J.-P. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 51, 34-36 (1997).
115. Suh, J., Paik, H. J. & Hwang, B. K. Ionization of polyethylenimine and polyallylamine at various pHs. Bioorg. Chem. 22, 318-327 (1994).
116. Forrest, M. L., Meister, G. E., Koerber, J. T. & Pack, D. W. Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm. Res. 21, 365-371 (2004).
117. Thomas, M. & Klibanov, A. M. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Natl Acad. Sci. USA 99, 14640-14645 (2002).
118. Tomalia, D. A., Naylor, A. M. & Goddard, W. A. Starburst cascade polymers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. Eng. 29, 138-175 (1990).
119. Haensler, J. & Szoka, F. C. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem. 4, 372-379 (1993).
120. Tanaka, S. et al. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamido amine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter. Cancer Gene Ther. 7, 1241-1249 (2000).
121. Rudolph, C., Lausier, J., Naundorf, S., Muller, R. H. & Rosenecker, J. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J. Gene Med. 2, 269-278 (2000).
122. Harada, Y. et al. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer. Cancer Gene Ther. 7, 27-36 (2000).
123. Marayuma-Tabata, H. et al. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene Ther. 7, 53-60 (2000).
124. Tang, M. X., Redemann, C. T. & Szoka, F. C. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug. Chem. 7, 703-714 (1996).
125. Tang, M. X. & Szoka, F. C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 4, 823-832 (1997).
126. Midoux, P., LeCam, E., Coulaud, D., Delain, E. & Pichon, C. Histidine containing peptides and polypeptides as nucleic acid vectors. Somat. Cell Mol. Genet. 27, 27-47 (2002).
127. Pack, D. W., Putnam, D. & Langer, R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol. Bioeng. 67, 217-223 (2000).
128. Ihm, J.-E. et al. High transfection efficiency of poly(4-vinylimidazole) as a new gene carrier. Bioconjug. Chem. 14, 707-708 (2003).
129. Midoux, P. & Monsigny M. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug. Chem. 10, 406-411 (1999).
130. Pichon, C., Roufai, M. B., Monsigny, M. & Midoux, P. Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides. Nucleic Acids Res. 28, 504-512 (2000).
131. Putnam, D., Gentry, C. A., Pack, D. W. & Langer, R. Polymer-based gene delivery with low cylotoxicity by a unique balance of side chain termini. Proc. Natl Acad. Sci. USA 98, 1200-1205 (2001).
132. Grimm, D. & Kay, M. A. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 3, 281-304 (2003).
133. Skehel, J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569 (2000).
134. Ren, J., Sharpe, J. C., Collier, R. J., London, R. J. & Loneon, E. Membrane translocation of charged residues at the tips of hydrophobic helices in the T domain of diphtheria toxin. Biochemistry 38, 976-984 (1999).
135. Tolstikov, V. V., Cole, R., Fang, H. & Pincus, S. H. Influence of endosome-destabilizing peptides on efficacy of anti-HIV immunotoxins. Bioconjug. Chem. 8, 38-43 (1997).
136. Subbarao, N. K., Parente, R. A., Szoka, F. C., Nadasdi, L. & Pongraca, K. pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry 26, 2964-2972 (1987).
137. Parente, R. A., Nir, S. & Szoka, F. C. pH-dependent fusion of phosphatidylcholine small vesicles. J. Biol. Chem. 263, 4724-4730 (1988).
138. Stayton, P. S. et al. in Biomimetic Materials and Design: Biointerfacial Strategies, Tissue Engineering, and Targeted Drug Delivery (eds Dillow, A. K. & Lowman, A. M.) 471-506 (Marcel Dekker Inc., 2002).
139. Thomas, J. L. & Tirrell, D. A. Polyelectrolyte-sensitized phospholipid vesicles. Acc. Chem. Res. 25, 336-342 (1992).
140. Thomas, J. L., Barton, S. W. & Tirrell, D. A. Membrane solubilization by a hydrophobic polyelectrolyte: surface activity and membrane binding. Biophys. J. 67, 1101-1106 (1994).
141. Murthy, N., Robichaud, J. R., Tirrell, D. A., Stayton, P. S. & Hoffman, A. S. The design and synthesis of polymers for eukaryotic membrane disruption. J. Control. Release 61, 137-143 (1999).
142. Murthy, N., Chang, I., Stayton, P. S. & Hoffman, A. S. pH-sensitive hemolysis by random copolymers of alkyl acrylates and acrylic acid. Macromol. Symp. 172, 49-55 (2001).
143. Cheung, C. Y., Murthy N., Stayton, P. S. & Hoffman, A. S. A pH-sensitive polymer that enhances cationic lipid-medlated gene transfer. Bioconjug. Chem. 12, 906-910 (2001).
144. Kyriakides, T. R. et al. pH-sensitive polymers that enhance intracellular drug delivery in vivo. J. Control. Release 78, 295-303 (2002).
145. Kiang, T. et al. Formulation of chitosan/DNA nanoparticles with poly(propylacrylic acid) enhances gene expression. J. Biomater. Sci. Polym. Ed. 15, 1405-1422 (2005).
146. Cheung, C. Y., Stayton, P. S. & Hoffman, A. S. Poly(propylacrylic acid)-mediated serum stabilization of cationic lipoplexes. J. Biomater. Sci. Polym. Ed. 16, 163-179 (2005).
147. Henry, S., Pirie, C., Stayton, P. S. & Hoffman, A. S. Membrane-disruption ability of maleic anhydride copolymers at endosomal pHs. Biomacromolecules (in the press).
148. Stephan, D. & Nabel, E. G. Gene and other biological therapies for vascular diseases. Fundam. Clin. Pharmacol. 11, 97-110 (1997).
149. Bulmus, V., Woodward, M., Lin, L., Stayton, P. S. & Hoffman, A. S. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J. Control. Release 93, 105-120 (2003).
150. El-Sayed, M., Hoffman, A. S. & Stayton, P. S. Influence of composition of novel pH-sensitive and glutathione-reactive polymeric carriers on their membrane-destabilizing activity. J. Control. Release (in the press).
151. Murthy, N., Campbell, J., Fausto, N., Hoffman, A. S. & Stayton, P. S. Bioinspired polymeric carriers than enhance intracellular delivery of biomolecular therapeutics. Bioconjug. Chem. 14, 412-419 (2003).
152. Murthy, N., Campbell, J., Fausto, N., Hoffman, A. S. & Stayton, P. S. Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides to hepatocytes. J. Control. Release 89, 365-374 (2003).
153. Gonzalez, H., Hwang, S. & Davis, M. New class of polymers for the delivery of macromolecular therapeutics. Bioconjug. Chem. 10, 1068-1074 (1999).
154. Hwang, S. J., Bellocq, N. C. & Davis, M. E. Effects of structure of cyclodextrin-containing polymers on gene delivery. Bioconjug. Chem. 12, 280-290 (2001).
155. Reineke, T. M. & Davis, M. E. Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from change centers. Bioconjug. Chem. 14, 247-254 (2003).
156. Reineke, T. M. & Davis, M. E. Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center type. Bioconjug. Chem. 14, 255-261 (2003).
157. Popielarski, S. R., Mishra, S. & Davis, M. E. Structural effects of carbohydrate-containing polycations on gene delivery. 3. cyclodextrin type and functionalization. Bioconjug. Chem. 14, 672-678 (2003).
158. Davis, M. E. et al. Self-assembling nucleic acid delivery vehicles via linear, water-soluble, cyclodextrin-containing polymers. Curr. Med. Chem. 11, 179-197 (2004).
159. Pun, S. H. & Davis, M. E. in Polymeric Gene Delivery (ed. Amiji, M.) 187-210 (CRC, Boca Raton; 2005).
160. Davis, M. E. & Brewster, M. E. Cyclodextrin-based pharmaceutics: past, present, and future. Nature Rev. Drug Discov. 3, 1023-1035 (2004).
161. Kihara, F., Arima, H., Tsutsumi, T., Hirayama, F. & Uekama, K. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin. Bioconjug. Chem. 13, 1211-1219 (2002).
162. Kihara, F., Arima, H., Tsutsumi, T., Hirayama, F. & Uekama, K. In vitro and in vivo gene transfer by an optimized α-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug. Chem. 14, 342-350 (2003).
163. Arima, H., Kihara, F., Hirayama, F. & Uekama, K, Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins. Bioconjug. Chem. 12, 476-484 (2001).
164. Forrest, M. L., Gabrielson, N. & Pack, D. W. Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery. Biotechnol. Bioeng. 89, 416-423 (2004).
165. Pun, S. H. et al. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug. Chem. 15, 831-840 (2004).
166. Pun, S. H. & Davis, M. Development of a non-viral gene delivery vehicle for systemic application. Bioconjug. Chem. 13, 630-639 (2002).
167. Bellocq, N., Pun, S. & Davis, M. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug. Chem. 14, 1122-1132 (2003).
168. Pun, S. et al. Biodistribution of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles. Cancer Biol. Ther. 3, 641-650 (2004).
169. Putnam, D. & Langer, R. Poly(4-hydroxy-L-proline ester): low-temperature polycondensation and plasmid DNA complexation. Macromolecules 32, 3568-3662 (1999).
170. Lim, Y.-B., Choi, Y. H. & Park, J.-S. A self-destroying polycationic polymer: biodegradable poly(4-hydroxy-L-proline ester). J. Am. Chem. Soc. 121, 5633-5639 (1999).
171. Lim, Y.-B., Kim, C.-H., Kim, K., Kim, S. W. & Park, J.-S. Development of a safe gene delivery system using biodegradable polymer, poly[α-(4-aminobutyl)-L-glycolic acid]. J. Am. Chem. Soc. 122, 6524-6525 (2000).
172. Lim, Y.-B. et al. Cationic hyperbranched poly(amino ester): a novel class of DNA condensing molecule with cationic surface, biodegradable three-dimensional structure, and tertiary amine groups in the interior. J. Am. Chem. Soc. 123, 2460-2461 (2001).
173. Koh, J. J. et al. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther. 7, 2099-2104 (2000).
174. Lynn, D. M. & Langer, R. Degradable poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J. Am. Chem. Soc. 122, 10761-10768 (2000).
175. Lynn, D. M., Amiji, M. M. & Langer, R. pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular pH. Angew. Chem. Int. Ed. Eng. 40, 1707-1710 (2001).
176. Lynn, D. M., Anderson, D. G., Putnam, D. & Langer, R. Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J. Am. Chem. Soc. 123, 8155-8156 (2001).
177. Little, S. R. et al. Poly-β amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc. Natl Acad. Sci. USA 101, 9534-9539 (2004).
178. Anderson, D. G. et al. A polymer library approach to suicide gene therapy for cancer. Proc. Natl Acad. Sci. USA 101, 16028-16033 (2004).
179. Forrest, M. L., Koerber, J. T. & Pack, D. W. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug. Chem. 14, 934-940 (2003).
180. Pichon, C. et al. Poly[Lys-(AEDTP)]: a cationic polymer that allows dissociation of pDNA/cationic polymer complexes in a reductive medium and enhances polyfection. Bioconjug. Chem. 13, 76-82 (2002).
181. Gosselin, M. A., Guo, W. & Lee, R. J. Efficient gene transfer using reversible cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. 12, 989-994 (2001).
182. Sonawane, N. D., Szoka, R. C. & Verkman, A. S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278, 44826-44831 (2003).